Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March.
July 8th, 2013 - News
June 27th, 2013 - News
June 26th, 2013 - News
April 28th, 2013 - News
Returns since its inception in May 2014 (through November 14th, 2024)